|
[1] WANG YQ, JIA RX, LIANG JH, et al. Dementia in China (2015-2050) estimated using the 1% population sampling survey in 2015[J]. Geriatr Gerontol Int, 2019, 19(11): 1096-1100. [2] SRIVASTAVA S, AHMAD R, KHARE SK. Alzheimer's disease and its treatment by different approaches: a review[J]. Eur J Med Chem, 2021, 216: 113320. [3] SHARMA K. Cholinesterase inhibitors as Alzheimer's therapeutics (review)[J]. Mol Med Rep, 2019, 20(2): 1479-1487. [4] DYER O. Injectable Alzheimer's drug lecanemab approved in US for use at home[J]. BMJ, 2025, 390: r1888. [5] FEDELE E. Anti-amyloid therapies for Alzheimer's disease and the amyloid cascade hypothesis[J]. Int J Mol Sci, 2023, 24(19): 14499. [6] ALAFUZOFF I, ARZBERGER T, AL-SARRAJ S, et al. Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe consortium[J]. Brain Pathol, 2008, 18(4): 484-496. [7] ANGELONI C, MALAGUTI M, HRELIA S. Antiglycative activity of sulforaphane: a new avenue to counteract neurodegeneration?[J]. Neural Regen Res, 2015, 10(11): 1750-1751. [8] WU YG, SONG LJ, YIN LJ, et al. The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer's disease[J]. Neural Regen Res, 2023, 18(5): 947-954. [9] BENEK O, AITKEN L, HROCH L, et al. A direct interaction between mitochondrial proteins and amyloid-β peptide and its significance for the progression and treatment of Alzheimer's disease[J]. Curr Med Chem, 2015, 22(9): 1056-1085. [10] MAHLEY RW. Apolipoprotein E4 targets mitochondria and the mitochondria-associated membrane complex in neuropathology, including Alzheimer's disease[J]. Curr Opin Neurobiol, 2023, 79: 102684. [11] CHORNENKYY Y, WANG WX, WEI A, et al. Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline[J]. Brain Pathol, 2019, 29(1): 3-17. [12] KHAN S, BARVE KH, KUMAR MS. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer's disease[J]. Curr Neuropharmacol, 2020, 18(11): 1106-1125. [13] 刘立权, 江萌, 张伊黎, 等. 石菖蒲挥发油成分改善阿尔茨海默病症状的作用及机制研究[J]. 浙江医学, 2024, 46(11): 1151-1156. [14] 胡慧艳, 文志强, 任婧婻, 等. 嗅闻佛手柑精油对阿尔兹海默症小鼠的神经行为的影响[J]. 华中农业大学学报, 2022(4): 151-157. [15] 崔勇华. 佛手精油对阿尔茨海默症模型动物和细胞的神经保护作用及其分子机制研究[D]. 无锡: 江南大学博士论文, 2023: 1-85. [16] 陈紫微, 张前, 何芳, 等. 栀子花精油芳香疗法对阿尔兹海默症双转基因模型小鼠运动及焦虑的影响[J]. 北京中医药大学学报, 2020, 43(7): 569-574. [17] 齐越, 刘冉, 贾冬, 等. 温郁金挥发油对Aβ25-35致阿尔兹海默病小鼠模型行为学的影响[J]. 实验动物科学, 2017, 34(5): 23-27. [18] BAHADORI BM, MAGGI F, ZENGIN G, et al. Essential oils of hedgenettles (Stachys inflata, S. lavandulifolia, and S. byzantina) have antioxidant, anti-Alzheimer, antidiabetic, and anti-obesity potential: A comparative study[J]. Ind Crops Prod, 2020, 145: 112089. [19] MURAKAMI Y, OHSAWA I, KASAHARA T, et al. Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde[J]. Neurobiol Aging, 2009, 30(2): 325-329. [20] HARA Y, MCKEEHAN N, FILLIT HM. Translating the biology of aging into novel therapeutics for Alzheimer disease[J]. Neurology, 2019, 92(2): 84-93. [21] CHONG CM, SU HX, LU JJ, et al. The effects of bioactive components from the rhizome of Salvia miltiorrhiza (Danshen) on the characteristics of Alzheimer's disease[J]. Chin Med, 2019, 14: 19. [22] 齐越, 秦文艳, 康凯, 等. 温郁金挥发油通过PI3K/Akt信号途径对阿尔茨海默模型小鼠tau蛋白磷酸化表达的影响[J]. 中国中医药信息杂志, 2017, 24(1): 45-48. [23] JEON S, HUR J, JEONG HJ, et al. SuHeXiang Wan essential oil alleviates amyloid beta induced memory impairment through inhibition of tau protein phosphorylation in mice[J]. Am J Chin Med, 2011, 39(5): 917-932. [24] ZUO X, GU YN, WANG C, et al. A systematic review of the anti-inflammatory and immunomodulatory properties of 16 essential oils of herbs[J]. Evid Based Complement Alternat Med, 2020, 2020: 8878927. [25] 宋琳, 敖丽梅, 朴钟源, 等. 中药对阿尔茨海默病抗氧化作用的实验研究进展[J]. 上海中医药杂志, 2016, 50(4): 97-101. [26] LV XF, FENG YY, MA R, et al. Effects of peppermint essential oil on learning and memory ability in APP/PS1 transgenic mice[J]. Molecules, 2022, 27(7): 2051. [27] AL-TAWARAH NM, AL-DMOUR RH, ABU HAJLEH MN, et al. Rosmarinus officinalis and Mentha piperita oils supplementation enhances memory in a rat model of scopolamine-induced Alzheimer's disease-like condition[J]. Nutrients, 2023, 15(6): 1547. [28] XU ZW, ZHOU XJ, HONG X, et al. Essential oil of Acorus tatarinowii Schott inhibits neuroinflammation by suppressing NLRP3 inflammasome activation in 3 × Tg-AD transgenic mice[J]. Phytomedicine, 2023, 112: 154695. [29] 邓敏贞, 黄丽平, 马阮昕, 等. 石菖蒲挥发油联合人参总皂苷通过调节PI3K/Akt/mTOR通路对痴呆模型APP/PS1双转基因小鼠的Aβ40和GFAP的影响[J]. 中药药理与临床, 2018, 34(4): 92-95. [30] SAXENA M, DUBEY R. Target enzyme in Alzheimer's disease: acetylcholinesterase inhibitors[J]. Curr Top Med Chem, 2019, 19(4): 264-275. [31] BOIANGIU RS, BAGCI E, DUMITRU G, et al. Angelica purpurascens (avé-lall.) gilli. essential oil improved brain function via cholinergic modulation and antioxidant effects in the scopolamine-induced zebrafish (Danio rerio) model[J]. Plants (Basel), 2022, 11(8): 1096. [32] LIU BN, KOU JY, LI FY, et al. Lemon essential oil ameliorates age-associated cognitive dysfunction via modulating hippocampal synaptic density and inhibiting acetylcholinesterase[J]. Aging (Albany NY), 2020, 12(9): 8622-8639. [33] MEDEIROS SRNA, BEZERRA IC, PEDROZA LAL, et al. Evaluation of Bauhinia ungulata Essential Oil as a New Acetylcholinesterase Inhibitor from an in silico and in vitro Perspective in the Northern Amazon of Brazil[J]. J Oleo Sci, 2024, 73(8): 1091-1104. [34] TERAL? K, OZBEYLI D, YIĞIT-HANŇLU D, et al. A comprehensive assessment of the cholinergic-supporting and cognitive-enhancing effects of Rosa damascena Mill. (Damask rose) essential oil on scopolamine-induced amnestic rats[J]. Brain Behav, 2024, 14(5): e3507. [35] ZHOU DD, LUO M, HUANG SY, et al. Effects and mechanisms of resveratrol on aging and age-related diseases[J]. Oxid Med Cell Longev, 2021, 2021: 9932218. [36] ZHAO X, HUANG XS, YANG C, et al. Artemisinin attenuates amyloid-induced brain inflammation and memory impairments by modulating TLR4/NF-κB signaling[J]. Int J Mol Sci, 2022, 23(11): 6354. [37] ASHOKKUMAR K, SIMAL-GANDARA J, MURUGAN M, et al. Nutmeg (Myristica fragrans Houtt.) essential oil: a review on its composition, biological, and pharmacological activities[J]. Phytother Res, 2022, 36(7): 2839-2851. [38] XU QQ, SU ZR, YANG W, et al. Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer's disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway[J]. J Neuroinflammation, 2023, 20(1): 19. [39] MOHAMED ME, YOUNIS NS, EL-BELTAGI HS, et al. The synergistic hepatoprotective activity of rosemary essential oil and curcumin: the role of the MEK/ERK pathway[J]. Molecules, 2022, 27(24): 8910. [40] BEJESHK MA, SAMAREH FEKRI M, NAJAFIPOUR H, et al. Anti-inflammatory and anti-remodeling effects of myrtenol in the lungs of asthmatic rats: Histopathological and biochemical findings[J]. Allergol Immunopathol (Madr), 2019, 47(2): 185-193. [41] ALAHMADY NF, ALKHULAIFI FM, ABDULLAH MM, et al. Biochemical characterization of chamomile essential oil: Antioxidant, antibacterial, anticancer and neuroprotective activity and potential treatment for Alzheimer's disease[J]. Saudi J Biol Sci, 2024, 31(2): 103912. [42] LIU FG, YANG YF, DONG HR, et al. Essential oil from Cinnamomum cassia Presl bark regulates macrophage polarization and ameliorates lipopolysaccharide-induced acute lung injury through TLR4/MyD88/NF-κB pathway[J]. Phytomedicine, 2024, 129: 155651. [43] 李文静, 肖帅, 郑琴, 等. 基于GC-MS技术和网络药理学探讨益智仁挥发油治疗阿尔茨海默病的作用机制[J]. 中国中药杂志, 2021, 46(12): 3052-3057. [44] CHORNENKYY Y, WANG WX, WEI A, et al. Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline[J]. Brain Pathol, 2019, 29(1): 3-17. [45] HUANG JH, XU ZW, YU CS, et al. The volatile oil of Acorus tatarinowii Schott ameliorates Alzheimer's disease through improving insulin resistance via activating the PI3K/AKT pathway[J]. Phytomedicine, 2024, 135: 156168. [46] CHA H, KIM S, SEO MS, et al. Effects of olfactory stimulation on cognitive function and behavior problems in older adults with dementia: a systematic literature review[J]. Geriatr Nurs, 2021, 42(5): 1210-1217. [47] 苗明三, 李孟艳, 田硕. 中药外用疗效新机制[J]. 中国药理学与毒理学杂志, 2019, 33(9): 653-654. [48] VORA LK, GHOLAP AD, HATVATE NT, et al. Essential oils for clinical aromatherapy: a comprehensive review[J]. J Ethnopharmacol, 2024, 330: 118180. [49] MA Y, LI YM, YIN R, et al. Therapeutic potential of aromatic plant extracts in Alzheimer's disease: Comprehensive review of their underlying mechanisms[J]. CNS Neurosci Ther, 2023, 29(8): 2045-2059. [50] SHI A, LONG Y, MA Y, et al. Natural essential oils derived from herbal medicines: a promising therapy strategy for treating cognitive impairment[J]. Front Aging Neurosci, 2023, 15: 1104269. [51] AVOLA R, FURNARI AG, GRAZIANO ACE, et al. Management of the brain: essential oils as promising neuroinflammation modulator in neurodegenerative diseases[J]. Antioxidants (Basel), 2024, 13(2): 178.
|